Oncotelic Therapeutics, Inc. Restricted Stock or Unit Expense
Oncotelic Therapeutics, Inc. (OTLC) reported Restricted Stock or Unit Expense of $0 for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestrictedStockExpense · last filed 2013-03-15
- Oncotelic Therapeutics, Inc. restricted stock or unit expense for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- Oncotelic Therapeutics, Inc. restricted stock or unit expense for fiscal 2011 was $20.00K, a 75.61% decline from fiscal 2010.
- Oncotelic Therapeutics, Inc. restricted stock or unit expense for fiscal 2010 was $82.00K.
| Period end | Restricted Stock or Unit Expense 12 month |
|---|---|
| 2012-12-31 | $0.00 10-K · filed 2013-03-15 |
| 2011-12-31 | $20.00K 10-K · filed 2013-03-15 |
| 2010-12-31 | $82.00K 10-K · filed 2013-03-15 |